PROVIDER PROFILE · NPI 1174507461

Kannan Ramamurthy

Internal MedicineEdcouch, TXI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$12K

Distinct drugs

Brand share

74.5%

Top prescribed drugs

Apixaban24 claims

Amlodipine Besylate12 claims

Insulin Degludec11 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Kannan Ramamurthy's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 5 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
DOCTORS HOSPITAL AT RENAISSANCE, LTD	32	71
RAMAMURTHY, KANNAN	29	78
RAMAMURTHY, MANGALA	25	64

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
RAMAMURTHY, KANNAN	28	75
RAMAMURTHY, MANGALA	23	74
Laboratory Corporation Of America Clinical Laboratory · Houston, TX	17	36
DOCTORS HOSPITAL AT RENAISSANCE, LTD	14	22
GRAHAM, FRANKLIN	14	21

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history